biology will deliver most of the returns in the stock market over the next 20 years
Life Biosciences Treats First Patient In Partial Cell Reprogramming Trial
Many users express optimism about Life Biosciences treating its first patient with partial cell reprogramming, highlighting longevity biotech's lucrative growth potential and strong returns for related companies.
Most Activity

@alc2022 Interesting take, but biology's been hyped for decades and still hasn't fully delivered. What makes you think this time is different?

@alc2022 Hey Antonio! Big fan of your work. I actually wrote a piece recently about Isomorphic Labs, would you be interested? Google AI biotech spin off. Also nice to see Duolingo winning today :)

@alc2022 My strategy analysis !
⬇️as follows 👇 👇 👇

@alc2022 My strategy analysis
👇 👇 👇

@alc2022 My strategy plan.
👇 👇 👇

@alc2022 $SDGR and $RXRX are an easy 10x from here over the next 3-5y

@alc2022 Sometimes the future feels too good to be true but it will be true

@alc2022 I get the hype but biotech has been a rollercoaster for ages, one FDA decision can wipe out years of gains.

@alc2022 The market implication is a long-duration biotech call with brutal dispersion. The winners will be platforms with repeatable delivery, clean safety data, and regulatory paths that turn science into reimbursable products.

@alc2022 Healthcare and biotech have been volatile for me, but if AI speeds up drug discovery, maybe this time it's different.

@alc2022 Partly true. We will need to develop better models via regulatory to move toward a more personalized approach to therapeutic development (I almost see it like getting a license to drive a car).

@alc2022 Feels like everyone's been saying biotech is the next big thing for a while now, but the real money always seems to go elsewhere. Still, with aging populations, it's hard to bet against it entirely.

@alc2022 People said that about tech 20 years ago, but biotech is a different beast—long timelines and regulatory hurdles make it risky.

@alc2022 Feels like a bold bet on something that's still pretty unpredictable. Biotech has huge potential but also burns through cash like crazy.

@CahyaWisnuArdi @alc2022 AI

@alc2022 What are the companies to watch?

@CahyaWisnuArdi @alc2022 What part hasn’t delivered? It’s the second most lucrative sector after tech. Larger and more profitable companies in biopharma than energy and banking. Biotech / biopharma is already huge, longevity tech could propel it higher than software/semis.

@alc2022 🚀I share my real-time TRADE alert (entry & exit points) on WhatsApp, free to join ·~~~✅ Click below to join my group 👇
Here’s the link: https://api.whatsapp.com/send/?phone=13192413119&text=join
➡️Reply "777" to WhatsApp : +13192413119
🎥 - DAILY LIVE TRADING 📖 - TRADE RECAPS ☢️ - PERSONAL STRATEGY

@alc2022 I will share my detailed trading plan (including entry and exit points, investment analysis, etc.) on WA. This might be helpful to you. Get it for free !🌐
👉Copy and reply with "777" to my WA to get it for free👉: 13476125585
My WA link:http://wa.me/13476125585/?text=join

@alc2022 I will share my detailed trading plan (including entry and exit points, investment analysis, etc.) on WA. This might be helpful to you. Get it for free 🌐
👉Copy and reply with "777" to my WA to get it for free👉: 13192413119
My WA link:http://wa.me/13192413119/?text=join